Atopic Dermatitis

The AJMC® Atopic Dermatitis compendium is a comprehensive resource for clinical news and expert insights for the chronic skin condition that typically develops in early childhood.

Dr Elaine Siegfried Discusses Skin Color, Socioeconomic Implications of Atopic Dermatitis Management

May 19th 2022, 3:45pm

Video

Elaine Siegfried, MD, professor of pediatrics and dermatology, Saint Louis University Health Sciences Center, explains the impact of socioeconomic status on the management of atopic dermatitis in the clinical setting.

Dupilumab Clinically Effective Long Term for Moderate to Severe Pediatric Atopic Dermatitis

May 17th 2022, 7:45pm

Article

Findings of the 52-week phase 3 LIBERTY AD PED-OLE trial showed dupilumab to have an adequate safety profile and incremental clinical benefit with continued use among pediatric patients with moderate to severe atopic dermatitis.

Dr Robert Sidbury Discusses Strategies to Promote Earlier Uptake of Novel Atopic Dermatitis Therapies

May 13th 2022, 1:20pm

Video

Robert Sidbury, MD, MPH, chief, division of dermatology, Seattle Children's Hospital, discussed the emergence of effective therapies for the management of atopic dermatitis and how dermatologists and other providers involved in patient care can better promote earlier use of these treatments.

Study Shows Caregivers Prefer Dermatology Specialists Over PCPs for Pediatric Atopic Dermatitis

May 10th 2022, 8:30pm

Article

Dermatology specialists were cited by diverse caregivers of children with atopic dermatitis (AD) to provide enhanced care delivery and improved AD disease control compared with primary care providers.

Dr Elaine Siegfried on Safety Considerations for JAK Inhibitors in Pediatric Atopic Dermatitis

May 6th 2022, 4:15pm

Video

Elaine Siegfried, MD, professor of pediatrics and dermatology, Saint Louis University Health Sciences Center, speaks on safety considerations for the use of Janus kinase (JAK) inhibitors in pediatric patients with atopic dermatitis.

High Disability Burden of Atopic Dermatitis Linked With Socioeconomic Status

May 4th 2022, 4:25pm

Article

Atopic dermatitis was associated with the greatest burden of disease compared with 2 other types of dermatitis, in which high incidence and disability-adjusted life-years rates corresponded with high sociodemographic index areas.

Dr Robert Sidbury on Mental Health Implications of Atopic Dermatitis

April 28th 2022, 2:20pm

Video

Robert Sidbury, MD, MPH, chief, Division of Dermatology, Seattle Children's Hospital, spoke on the mental health comorbidity risk linked with atopic dermatitis and how dermatologists can play a role in managing behavioral care needs of at-risk patients.

Improved Severity of Atopic Dermatitis Achieved With Adjuvant Dupilumab, Tacrolimus

April 25th 2022, 5:33pm

Article

More patients with atopic dermatitis achieved mild disease severity by 1 month of treatment with adjuvant dupilumab and tacrolimus vs dupilumab alone.

Dr Elaine Siegfried on Considerations for Systemic Therapy Use in Pediatric Atopic Dermatitis

April 20th 2022, 6:37pm

Video

Elaine Siegfried, MD, professor of pediatrics and dermatology, Saint Louis University Health Sciences Center, discusses several pediatric patient populations with atopic dermatitis who are candidates for the use of systemic therapies.

Investigating Lifestyle Behaviors Associated With Moderate to Severe Atopic Dermatitis

April 18th 2022, 6:46pm

Article

Several modifiable lifestyle factors were associated with moderate to severe atopic dermatitis in a patient cohort from the Netherlands, including smoking, alcohol consumption, and stress.